Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPICIN vs RIFAMPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPICIN vs RIFAMPIN: Safety Overview

Metric RIFAMPICIN RIFAMPIN
Total FAERS Reports 179 13,347
Deaths Reported 34 1,439
Death Rate 19.0% 10.8%
Hospitalizations 79 5,764
Average Patient Age 46.8 yrs 51.7 yrs
% Female Patients N/A 47.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued